MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > MEDMIRA SMELL TEST

<< Previous

Bullboard Posts

Next >>

Post by goldyhawkon Nov 25, 2023 12:50pm

213 Views

Post# 35752828

MEDMIRA SMELL TEST

I wish all small shareholders at MEDMIRA an extra good financial report this next week
MEDMIRA looks very good from the road
but when their tests get up close and personal with regulators things slow down or stop
They just can’t seem to pass the smell test

COME ON MEDMIRA —-
YOU are an old company and have been given a million chances or more
NO MORE EXCUSES
NOONE ELSE IS HOLDING MEDMIRA BACK
TIME TO END THE LOSSES
PROFIT REQUIRED NOW
ENOUGH POSTURING AND INNUENDO

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages